Cite
HARVARD Citation
Novi, G. et al. (2020). Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS. Neurology. 7 (3), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Novi, G. et al. (2020). Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS. Neurology. 7 (3), p. . [Online].